Abstract
Purpose
The etiology of allergic rhinitis (AR) is closely correlated with the complex interactions between genetic and environmental factors. This study explored the effect of single-nucleotide polymorphisms (SNPs) of CYSLTR1 gene on the risk of AR and clinical response to montelukast treatment in children.
Methods
A total of 135 children with AR and 100 healthy children were included for subsequent analyses. Genotype and allele distribution of rs321029 SNP of CYSLTR1 gene and inflammatory mediators were detected and compared between AR and healthy children.
Results
Genotype and allele frequency of rs321029 SNP of CYSLTR1 gene showed no difference between children with AR and controls or between AR cases with different severity. The total montelukast effective rate of wide-type genotype TT children was significantly higher than variants genotype CC children.
Conclusion
Polymorphism of rs321029 on CYSLTR1 gene is not related to the susceptibility and severity of AR in children, but it is closely related with the efficacy of montelukast on AR.
Similar content being viewed by others
References
Eifan AO, Durham SR (2016) Pathogenesis of rhinitis. Clin Exp Allergy 46(9):1139–1151. https://doi.org/10.1111/cea.12780
Zhang Y, Zhang L (2014) Prevalence of allergic rhinitis in china. Allergy Asthma Immunol Res 6(2):105–113. https://doi.org/10.4168/aair.2014.6.2.105
Nathan RA (2007) The burden of allergic rhinitis. Allergy Asthma Proc 28(1):3–9. https://doi.org/10.2500/aap.2007.28.2934
Al Heialy S, McGovern TK, Martin JG (2011) Insights into asthmatic airway remodelling through murine models. Respirology (Carlton, Vic) 16(4):589–597. https://doi.org/10.1111/j.1440-1843.2011.01974.x
Basavarajappa D, Wan M, Lukic A, Steinhilber D, Samuelsson B, Rådmark O (2014) Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis. Proc Natl Acad Sci USA 111(31):11371–11376. https://doi.org/10.1073/pnas.1410983111
Figueroa DJ, Borish L, Baramki D, Philip G, Austin CP, Evans JF (2003) Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy 33(10):1380–1388. https://doi.org/10.1046/j.1365-2222.2003.01786.x
Nayak A (2004) A review of montelukast in the treatment of asthma and allergic rhinitis. Expert Opin Pharmacother 5(3):679–686. https://doi.org/10.1517/14656566.5.3.679
Telleria JJ, Blanco-Quiros A, Varillas D, Armentia A, Fernandez-Carvajal I, Jesus Alonso M, Diez I (2008) ALOX5 promoter genotype and response to montelukast in moderate persistent asthma. Respir Med 102(6):857–861. https://doi.org/10.1016/j.rmed.2008.01.011
Asano K, Shiomi T, Hasegawa N, Nakamura H, Kudo H, Matsuzaki T, Hakuno H, Fukunaga K, Suzuki Y, Kanazawa M, Yamaguchi K (2002) Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast. Japanese Patients Moderate Asthma Pharmacogenetics 12(7):565–570. https://doi.org/10.1097/00008571-200210000-00009
Lima JJ, Zhang S, Grant A, Shao L, Tantisira KG, Allayee H, Wang J, Sylvester J, Holbrook J, Wise R, Weiss ST, Barnes K (2006) Influence of leukotriene pathway polymorphisms on response to montelukast in asthma. Am J Respir Crit Care Med 173(4):379–385. https://doi.org/10.1164/rccm.200509-1412OC
Zhang J, Migita O, Koga M, Shibasaki M, Arinami T, Noguchi E (2006) Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitis. Pediatric Allergy Immunol 17(4):242–249. https://doi.org/10.1111/j.1399-3038.2005.00347.x
Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, Aït-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8–160. https://doi.org/10.1111/j.1398-9995.2007.01620.x
Busse W, Kraft M (2005) Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy. Chest 127(4):1312–1326. https://doi.org/10.1378/chest.127.4.1312
Shirasaki H, Himi T (2016) Role of cysteinyl leukotrienes in allergic rhinitis. Adv Otorhinolaryngol 77:40–45. https://doi.org/10.1159/000441871
Shirasaki H, Kanaizumi E, Watanabe K, Matsui T, Sato J, Narita S, Rautiainen M, Himi T (2002) Expression and localization of the cysteinyl leukotriene 1 receptor in human nasal mucosa. Clin Exp Allergy 32(7):1007–1012. https://doi.org/10.1046/j.1365-2222.2002.01425.x
Kim SH, Ye YM, Hur GY, Lee SK, Sampson AP, Lee HY, Park HS (2007) CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. Pharmacogenomics 8(9):1143–1150. https://doi.org/10.2217/14622416.8.9.1143
Arriba-Mendez S, Sanz C, Isidoro-Garcia M, Davild I, Laffond E, Horeno E, Avila C, Lorente F (2006) 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis. Pediatric Allergy Immunol 17(5):323–328. https://doi.org/10.1111/j.1399-3038.2006.00416.x
Kim SH, Oh JM, Kim YS, Palmer LJ, Suh CH, Nahm DH, Park HS (2006) Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males. Clin Exp Allergy 36(4):433–439. https://doi.org/10.1111/j.1365-2222.2006.02457.x
Peters-Golden M, Gleason MM, Togias A (2006) Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clinical Exp Allergy 36(6):689–703. https://doi.org/10.1111/j.1365-2222.2006.02498.x
Funding
No source of funding.
Author information
Authors and Affiliations
Contributions
All authors contributed significantly to the work, have seen and approved the manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
Ethics approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Shandong Provincial Hospital Affiliated to Shandong First Medical University.
Consent to participate/publication
Informed consent was obtained from all the children' parents for both participation and publication of the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhao, M., Li, H. & Li, H. The relevance of CYSLTR1 gene polymorphism to the severity of allergic rhinitis and clinical responsiveness of montelukast in children. Eur Arch Otorhinolaryngol 278, 4847–4853 (2021). https://doi.org/10.1007/s00405-021-06771-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-021-06771-z